Keywords

active psoriatic arthritis, chronic obstructive pulmonary disease, chronic thromboembolic pulmonary hypertension, diabetes mellitus, grass pollen-induced allergic rhinitis

Authors

1. Sigler, Jeff PharmD

Abstract

Abstract: This article highlights important prescribing information for new drugs approved by the FDA over the last year. These include albiglutide, apremilast, dapagliflozin, insulin human inhalation powder, riociguat, timothy grass pollen allergen extract, umeclidinium and vilanterol inhalation powder, and vorapaxar.